BioCentury
ARTICLE | Company News

Cureon, Pantheco deal

May 26, 2003 7:00 AM UTC

The companies merged to form Santaris Pharma A/S, which will focus on developing cancer therapeutics. The combined company has DKK 135 million ($21 million) in cash, which Santaris said should last t...